Stock OBD OXFORD BIODYNAMICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Market Closed - London S.E.
Other stock markets
 09:05:09 10/05/2024 pm IST 		5-day change 1st Jan Change
7.88 GBX +1.03% Intraday chart for Oxford BioDynamics Plc -1.50% -71.86%
03/04 Oxford BioDynamics reaches "important milestone" with new laboratory AN
03/04 Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxford BioDynamics reaches "important milestone" with new laboratory
AN
Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test
CI
FireAngel CFO resigns; ECR Minerals raises GBP585,000
AN
EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal
AN
Oxford BioDynamics plunges as annual loss widens; revenue up
AN
Oxford BioDynamics plunge as annual profit rises; revenue up
AN
Oxford BioDynamics shares plunge as annual revenue widens; revenue up
AN
AIM WINNERS & LOSERS: James Cropper falls on lower outlook
AN
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Revenue GBP510,000
MT
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Loss GBX-7.30
MT
Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2023
CI
Oxford BioDynamics Strikes Deal with Bupa for Access to Blood Test
MT
Oxford BioDynamics in deal with Bupa to expand blood test access
AN
Oxford BioDynamics, Plc Announces a Strategic Agreement to Give Bupa Patients Access to OBD'sEpiSwitch CiRT
CI
Oxford Biodynamics Surges 92% With Early Launch of Prostate Screening Test
MT
Oxford BioDynamics Plc Launches 94% Accurate PSE Test in US and UK
CI
Oxford BioDynamics Plc Announces Validation of Its Episwitch Prostate Screening Test in Its US Clinical (CLIA-Certified) Laboratory Is Now Complete, Ahead of Schedule
CI
Oxford BioDynamics half-year loss widens; outlook remains uncertain
AN
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports Fiscal H1 Revenue GBP220,000
MT
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports Fiscal H1 Loss GBX-3.20
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OBD Stock
  4. News Oxford BioDynamics Plc
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW